Showing 1 - 15 results of 15 for search 'Duane D. Miller', query time: 0.04s Refine Results
  1. 1
    Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System

    Non-Musculoskeletal Benefits of Vitamin D beyond the Musculoskeletal System by Sicheng Zhang, Duane D. Miller, Wei Li

    Published 2021-02-01
    Get full text
    Article
  2. 2
    The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma

    The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma by Hongmei Cui, Hongmei Cui, Qinghui Wang, Duane D. Miller, Wei Li

    Published 2021-03-01
    Get full text
    Article
  3. 3
    Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy

    Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy by Hao Chen, Zongtao Lin, Kinsie E. Arnst, Duane D. Miller, Wei Li

    Published 2017-08-01
    Get full text
    Article
  4. 4
    Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma

    Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma by Chuanhe Yang, Yinan Wang, Michelle M. Sims, Yali He, Duane D. Miller, Lawrence M. Pfeffer

    Published 2021-09-01
    Get full text
    Article
  5. 5
    Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling.

    Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling. by Ramesh Narayanan, Sunjoo Ahn, Misty D Cheney, Muralimohan Yepuru, Duane D Miller, Mitchell S Steiner, James T Dalton

    Published 2014-01-01
    Get full text
    Article
  6. 6
    An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer

    An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer by Michael L. Mohler, Arunima Sikdar, Suriyan Ponnusamy, Dong-Jin Hwang, Yali He, Duane D. Miller, Ramesh Narayanan

    Published 2021-02-01
    Get full text
    Article
  7. 7
    Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties.

    Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties. by Min Xiao, Jin Wang, Zongtao Lin, Yan Lu, Zhenmei Li, Stephen W White, Duane D Miller, Wei Li

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Design, Synthesis and Biological Evaluation of Novel 5H-Chromenopyridines as Potential Anti-Cancer Agents

    Design, Synthesis and Biological Evaluation of Novel 5H-Chromenopyridines as Potential Anti-Cancer Agents by Souvik Banerjee, Jin Wang, Susan Pfeffer, Dejian Ma, Lawrence M. Pfeffer, Shivaputra A. Patil, Wei Li, Duane D. Miller

    Published 2015-09-01
    Get full text
    Article
  9. 9
    Computationally identified novel agonists for GPRC6A.

    Computationally identified novel agonists for GPRC6A. by Min Pi, Karan Kapoor, Ruisong Ye, Dong-Jin Hwang, Duane D Miller, Jeremy C Smith, Jerome Baudry, L Darryl Quarles

    Published 2018-01-01
    Get full text
    Article
  10. 10
    Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK.

    Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK. by Jordan J Toutounchian, Jena J Steinle, Patrudu S Makena, Christopher M Waters, Matthew W Wilson, Barrett G Haik, Duane D Miller, Charles R Yates

    Published 2014-01-01
    Get full text
    Article
  11. 11
    Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis

    Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis by Raisa I. Krutilina, Kelli L. Hartman, Damilola Oluwalana, Hilaire C. Playa, Deanna N. Parke, Hao Chen, Duane D. Miller, Wei Li, Tiffany N. Seagroves

    Published 2022-10-01
    Get full text
    Article
  12. 12
    17,20S(OH)<sub>2</sub>pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model

    17,20S(OH)<sub>2</sub>pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model by Monica L. Brown Lobbins, Imara-Safi O. Scott, Andrzej T. Slominski, Karen A. Hasty, Sicheng Zhang, Duane D. Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Tejesh S. Patel, Linda K. Myers, Arnold E. Postlethwaite

    Published 2021-08-01
    Get full text
    Article
  13. 13
    Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer

    Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer by Vivek K. Kashyap, Qinghui Wang, Saini Setua, Prashanth K. B. Nagesh, Neeraj Chauhan, Sonam Kumari, Pallabita Chowdhury, Duane D. Miller, Murali M. Yallapu, Wei Li, Meena Jaggi, Bilal Bin Hafeez, Subhash C. Chauhan

    Published 2019-01-01
    Get full text
    Article
  14. 14
    Modulation by 17,20S(OH)<sub>2</sub>pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis

    Modulation by 17,20S(OH)<sub>2</sub>pD of Fibrosis-Related Mediators in Dermal Fibroblast Lines from Healthy Donors and from Patients with Systemic Sclerosis by Monica L. Brown Lobbins, Andrzej T. Slominski, Karen A. Hasty, Sicheng Zhang, Duane D. Miller, Wei Li, Tae-Kang Kim, Zorica Janjetovic, Robert C. Tuckey, Imara-Safi O. Scott, Linda K. Myers, Arnold E. Postlethwaite

    Published 2021-12-01
    Get full text
    Article
  15. 15
    Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype

    Identification of a targetable JAK-STAT enriched androgen receptor and androgen receptor splice variant positive triple-negative breast cancer subtype by Sarah Asemota, Wendy Effah, Kirsten L. Young, Jeremiah Holt, Linnea Cripe, Suriyan Ponnusamy, Thirumagal Thiyagarajan, Dong-Jin Hwang, Yali He, Keely Mcnamara, Daniel Johnson, Yinan Wang, Brandy Grimes, Yekta Khosrosereshki, T.J. Hollingsworth, Martin D. Fleming, Frances E. Pritchard, Ashley Hendrix, Farhan Khan, Meiyun Fan, Liza Makowski, Zheng Yin, Hironobu Sasano, D. Neil Hayes, Lawrence M. Pfeffer, Duane D. Miller, Ramesh Narayanan

    Published 2023-12-01
    Get full text
    Article

Search Tools: